NVS (NVS)

$290.7B
Market Cap
21.0
P/E Ratio
0.50
Beta
3.15%
Dividend Yield
Piotroski 8/9Altman Z 3.8 SafeBeneish M -2.52 CleanROIC−WACC +8.9%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 8/9, Altman Z 3.8 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency of NVS demonstrates robust fundamental quality, evidenced by a substantial ROIC-WACC spread of 8.9%, indicating the firm generates returns significantly above its cost of capital. This profitability is underpinned by exceptional margin expansion rather than leverage or turnover; with net margins at 24.7% and gross margins soaring to 75.8%, DuPont decomposition reveals that operating efficiency, not financial engineering, drives equity generation. Credit risk metrics further corroborate this stability: a Piotroski F-Score of 8/9 signals strong balance sheet health and earnings quality, while an Altman Z-Score of 3.8 places the firm safely within safe territory regarding bankruptcy probability. Additionally, a Beneish M-Score of -2.52 suggests management has low incentives to manipulate earnings, reinforcing confidence in the reported financial trajectory alongside consistent revenue growth of 9.6% year-over-year.

Valuation metrics present a divergence between current market pricing and intrinsic value estimates derived from discounted cash flow analysis. The stock trades at a forward P/E multiple of 21.0x; without specific historical or sector benchmarks provided, this figure serves as the primary comparative anchor for assessing whether the price reflects growth expectations appropriately. However, the DCF model implies a fair value of $197 per share, which acts as a critical reference point against current market levels to gauge potential upside or downside compression. This valuation gap suggests the market may be pricing in specific growth assumptions that differ from those embedded in the cash flow projections, requiring investors to assess whether the 24.7% net margin sustainability justifies the premium relative to the implied DCF target.

Risk assessment relies heavily on the provided integrity scores and lack of additional volatility data. The combination of a high F-Score and low M-Score mitigates typical concerns regarding earnings manipulation or deteriorating financial health, suggesting that downside risks are primarily tied to macroeconomic headwinds rather than internal governance failures. While insider activity and specific factor alpha metrics were not supplied in the input data, the strong fundamental profile implies resilience against standard value traps. Ultimately, the risk/reward dynamic appears favorable for investors comfortable with the company's high-margin business model, provided they believe the DCF-derived fair value is achievable given the current multiple expansion or contraction trajectory.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%7.6%9.6%
2%$239$166$119
3%$311$197$134
4%$456$245$154

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=7.6%, terminal growth 3%. Fair value $197 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

8/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
3.8
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.52
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

75.8%
Gross Margin
24.7%
Net Margin
16.5%
ROIC
7.6%
WACC
ROIC − WACC Spread: +8.9%— Positive value creation spread.
+9.6%
Revenue Growth (YoY)
+17.1%
Earnings Growth (YoY)
15.2B
Free Cash Flow
51%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

1.38x
Debt / Equity
1.12x
Current Ratio
15.3x
Interest Coverage
0.7x
Net Debt / EBITDA
4.96%
FCF Yield
22.8B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $2.17
Act: $2.28
+5.0%
Q3
✓ Beat
Est: $2.37
Act: $2.42
+2.0%
Q2
✗ Miss
Est: $2.31
Act: $2.25
-2.6%
Q1
✓ Beat
Est: $2.00
Act: $2.03
+1.3%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

15.2
Forward P/E
PEG Ratio
6.22
Price/Book
2M
Avg Volume
$170.46
52W High
$97.72
52W Low
52W Range Position

NVS Capital Efficiency

How efficiently does NVS convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$15.2B
EBITDA
$22.8B
FCF Conversion
67%
Reinvestment Rate
33%
67% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
16.5%
ROIC − WACC Spread
8.9%

NVS converts 67% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 8.9% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-144,541$149.75$680,014.75
2026-05-0717,120$148.36$2.5M
2026-05-0168$147.85$10,053.8
2026-04-29309$145.50$44,959.5
2026-04-2849,818$144.19$7.2M
2026-04-272,580$145.47$375,312.6
2026-04-24134$147.48$19,762.32
2026-04-231,159$147.32$170,743.88
2026-04-2231$147.97$4,587.07
2026-04-20108$151.97$16,412.76
2026-04-16176,379$152.08$26.8M
2026-04-139,211$154.05$1.4M
2026-03-31398$150.36$59,843.28
2026-03-2574,898$148.61$11.1M
2026-03-24376$148.09$55,681.84
2026-03-239$146.03$1,314.27
2026-03-17195,213$154.87$30.2M
2026-03-139,412$154.25$1.5M
2026-03-12256$155.80$39,884.8
2026-03-1169,524$161.59$11.2M
2026-03-091,596$160.12$255,551.52
2026-03-06207$161.01$33,329.07
2026-03-0567,363$165.15$11.1M
2026-03-036,848$166.87$1.1M
2026-03-02162$168.62$27,316.44
2026-02-2755$165.51$9,103.05
2026-02-11987,873$158.20$156.3M
2026-02-1017$157.05$2,669.85
2026-02-09158$156.42$24,714.36
2026-02-067,859$153.95$1.2M

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare NVS to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.